State-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PET

被引：39

作者：

Carlier, Thomas ^{[1
,2
]}

Bailly, Clement ^{[1
]}

机构：

[1] Univ Hosp, Nucl Med Dept, Pl Alexis Ricordeau, F-44093 Nantes, France

[2] CNRS, CRCNA, INSERM, UMR 6299,U892, Nantes, France

来源：

FRONTIERS IN MEDICINE | 2015年 / 2卷

关键词：

nuclearmedicine; PET; follow-up; oncology; quantification;

D O I：

10.3389/fmed.2015.00018

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

F-18-fluoro-2-deoxyglucose ((18)F-FDG) positron emission tomography (PET) is an important tool in oncology. Its use has greatly progressed from initial diagnosis to staging and patient monitoring. The information derived from F-18-FDG-PET allowed the development of a wide range of PET quantitative analysis techniques ranging from simple semi-quantitative methods like the standardized uptake value (SUV) to "high order metrics" that require a segmentation step and additional image processing. In this review, these methods are discussed, focusing particularly on the available methodologies that can be used in clinical trials as well as their current applications in international consensus for PET interpretation in lymphoma and solid tumors.

引用

页数：12

共 126 条

[1] A Systematic Review of the Factors Affecting Accuracy of SUV Measurements [J].

Adams, Michael C. ;

Turkington, Timothy G. ;

Wilson, Joshua M. ;

Wong, Terence Z. .

AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 195 (02) :310-320

[2] Measuring Response with FDG-PET: Methodological Aspects [J].

Allen-Auerbach, Martin ;

Weber, Wolfgang A. .

ONCOLOGIST, 2009, 14 (04) :369-377

[3] Predicting Future Morphological Changes of Lesions from Radiotracer Uptake in 18F-FDG-PET Images [J].

Bagci, Ulas ;

Yao, Jianhua ;

Miller-Jaster, Kirsten ;

Chen, Xinjian ;

Mollura, Daniel J. .

PLOS ONE, 2013, 8 (02)

[4] Tumor Quantification in Clinical Positron Emission Tomography [J].

Bai, Bing ;

Bading, James ;

Conti, Peter S. .

THERANOSTICS, 2013, 3 (10) :787-801

[5] Improving PET spatial resolution and detectability for prostate cancer imaging [J].

Bal, H. ;

Guerin, L. ;

Casey, M. E. ;

Conti, M. ;

Eriksson, L. ;

Michel, C. ;

Fanti, S. ;

Pettinato, C. ;

Adler, S. ;

Choyke, P. .

PHYSICS IN MEDICINE AND BIOLOGY, 2014, 59 (15) :4411-4426

[6] Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group [J].

Barrington, Sally F. ;

Mikhaeel, N. George ;

Kostakoglu, Lale ;

Meignan, Michel ;

Hutchings, Martin ;

Mueeller, Stefan P. ;

Schwartz, Lawrence H. ;

Zucca, Emanuele ;

Fisher, Richard I. ;

Trotman, Judith ;

Hoekstra, Otto S. ;

Hicks, Rodney J. ;

O'Doherty, Michael J. ;

Hustinx, Roland ;

Biggi, Alberto ;

Cheson, Bruce D. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :3048-+

[7] FDG PET/CT methodology for evaluation of treatment response in lymphoma: from "graded visual analysis" and "semiquantitative SUVmax" to global disease burden assessment [J].

Basu, Sandip ;

Zaidi, Habib ;

Salavati, Ali ;

Hess, Soren ;

Carlsen, Poul Flemming Hoilund ;

Alavi, Abass .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (11) :2158-2160

[8] A novel fuzzy C-means algorithm for unsupervised heterogeneous tumor quantification in PET [J].

Belhassen, Saoussen ;

Zaidi, Habib .

MEDICAL PHYSICS, 2010, 37 (03) :1309-1324

[9] Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: a novel approach with fluorodeoxyglucose-PET [J].

Berkowitz, Arnold ;

Basu, Sandip ;

Srinivas, Shyam ;

Sankaran, Shrinkanthan ;

Schuster, Stephen ;

Alavi, Abass .

NUCLEAR MEDICINE COMMUNICATIONS, 2008, 29 (06) :521-526

[10] Variations in Clinical PET/CT Operations: Results of an International Survey of Active PET/CT Users [J].

Beyer, Thomas ;

Czernin, Johannes ;

Freudenberg, Lutz S. .

JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (02) :303-310

← 1 2 3 4 5 6 7 8 9 10 →